Live Oral Salmonella enterica Serovar Typhi Vaccines Ty21a and CVD 909 Induce Opsonophagocytic Functional Antibodies in Humans That Cross-React withS. Paratyphi A andS. Paratyphi B
Open Access
- 15 January 2014
- journal article
- clinical trial
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 21 (3), 427-434
- https://doi.org/10.1128/cvi.00786-13
Abstract
Live oral Salmonella enterica serovar Typhi vaccine Ty21a induces specific antibodies that cross-react against Salmonella enterica serovar Paratyphi A and Salmonella enterica serovar Paratyphi B, although their functional role in clearance remains unknown. We utilized an in vitro assay with THP-1 macrophages to compare the phagocytosis and survival of Salmonella opsonized with heat-inactivated human sera obtained before and after vaccination with Ty21a or a live oral S. Typhi vaccine, CVD 909. Opsonization with postvaccination sera predominantly increased the phagocytosis of S. Typhi relative to the corresponding prevaccination sera, and increases were also observed with S. Paratyphi A and S. Paratyphi B, albeit of lower magnitudes. Relative to prevaccination sera, opsonization with the postvaccination sera reduced the survival inside macrophages of S. Typhi but not of S. Paratyphi A or S. Paratyphi B. Higher anti-S. Typhi O antigen (lipopolysaccharide [LPS]) IgG, but not IgA, antibody titers correlated significantly with postvaccination increases in opsonophagocytosis. No differences were observed between immunization with four doses of Ty21a or one dose of CVD 909. Ty21a and CVD 909 induced cross-reactive functional antibodies, predominantly against S. Typhi. IgG anti-LPS antibodies may be important in phagocytic clearance of these organisms. Therefore, measurement of functional antibodies might be important in assessing the immunogenicity of a new generation of typhoid and paratyphoid A vaccines. (The CVD 909 study has been registered at ClinicalTrials.gov under registration no. NCT00326443.)Keywords
This publication has 50 references indexed in Scilit:
- Impact of Oral Typhoid Vaccination on the Human Gut Microbiota and Correlations with S. Typhi-Specific Immunological ResponsesPLOS ONE, 2013
- Live Oral Typhoid Vaccine Ty21a Induces Cross-Reactive Humoral Immune Responses against Salmonella enterica Serovar Paratyphi A andS. Paratyphi B in HumansClinical and Vaccine Immunology, 2012
- Antibodies in Action: Role of Human Opsonins in Killing Salmonella enterica Serovar TyphiInfection and Immunity, 2011
- Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD− S. Typhi-specific IgA and IgG B memory cells in humansClinical Immunology, 2010
- Ex VivoKinetics of Early and Long-Term Multifunctional Human Leukocyte Antigen E-Specific CD8+Cells in Volunteers Immunized with the Ty21a Typhoid VaccineClinical and Vaccine Immunology, 2010
- Complement: a key system for immune surveillance and homeostasisNature Immunology, 2010
- Global Trends in Typhoid and Paratyphoid FeverClinical Infectious Diseases, 2010
- Pseudogene accumulation in the evolutionary histories of Salmonella enterica serovars Paratyphi A and TyphiBMC Genomics, 2009
- Generation of specific effector and memory T cells with gut- and secondary lymphoid tissue- homing potential by oral attenuated CVD 909 typhoid vaccine in humansMucosal Immunology, 2008
- Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909Vaccine, 2006